LU87605A1 - Nouveaux derives de la methoxycarbonyl-2 n-n'-di-(trimethoxy-benzoyle)piperazine,un procede pour leur preparation et compositions therapeutiques en contenant - Google Patents

Nouveaux derives de la methoxycarbonyl-2 n-n'-di-(trimethoxy-benzoyle)piperazine,un procede pour leur preparation et compositions therapeutiques en contenant Download PDF

Info

Publication number: LU87605A1
Authority: LU; Luxembourg
Prior art keywords: piperazine; trimethoxy; benzoyl; formula; compound
Prior art date: 1988-10-11

Application number

LU87605A

Other languages

English (en)

French (fr)

Inventor

Eduardo Pirotsky

Georges Dive

Jean-Jacques Godfroid

Francoise Heymans

Pierre Braquet

Original Assignee

Scras

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-11

Filing date

1989-10-10

Publication date

1990-02-07

1989-10-10 Application filed by Scras filed Critical Scras

1990-02-07 Publication of LU87605A1 publication Critical patent/LU87605A1/fr

Links

238000000034 method Methods 0.000 title claims description 7
239000000203 mixture Substances 0.000 title claims description 7
238000002360 preparation method Methods 0.000 title claims description 6
230000008569 process Effects 0.000 title claims description 6
230000001225 therapeutic effect Effects 0.000 title claims description 3
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 44
150000001875 compounds Chemical class 0.000 claims description 34
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 30
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
125000004432 carbon atom Chemical group C* 0.000 claims description 4
125000001424 substituent group Chemical group 0.000 claims description 4
239000000460 chlorine Substances 0.000 claims description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
229910052763 palladium Inorganic materials 0.000 claims description 3
150000004885 piperazines Chemical class 0.000 claims description 3
229940066771 systemic antihistamines piperazine derivative Drugs 0.000 claims description 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
125000000217 alkyl group Chemical group 0.000 claims description 2
239000000010 aprotic solvent Substances 0.000 claims description 2
PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 claims description 2
229910052801 chlorine Inorganic materials 0.000 claims description 2
125000000753 cycloalkyl group Chemical group 0.000 claims description 2
229910052739 hydrogen Inorganic materials 0.000 claims description 2
239000001257 hydrogen Substances 0.000 claims description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
-1 monosubstituted piperazine Chemical class 0.000 claims description 2
125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 claims description 2
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
238000001990 intravenous administration Methods 0.000 claims 1
239000000546 pharmaceutical excipient Substances 0.000 claims 1
229960005141 piperazine Drugs 0.000 description 26
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 23
238000005481 NMR spectroscopy Methods 0.000 description 18
230000008018 melting Effects 0.000 description 13
238000002844 melting Methods 0.000 description 13
FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 12
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
101150041968 CDC13 gene Proteins 0.000 description 9
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 9
150000001408 amides Chemical class 0.000 description 9
238000005160 1H NMR spectroscopy Methods 0.000 description 8
150000002148 esters Chemical class 0.000 description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
239000003480 eluent Substances 0.000 description 4
238000001704 evaporation Methods 0.000 description 4
230000008020 evaporation Effects 0.000 description 4
239000000741 silica gel Substances 0.000 description 4
229910002027 silica gel Inorganic materials 0.000 description 4
0 *C(OCC(C1)NCCN1I)=O Chemical compound *C(OCC(C1)NCCN1I)=O 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 2
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
241000283977 Oryctolagus Species 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
RVOJTCZRIKWHDX-UHFFFAOYSA-N cyclohexanecarbonyl chloride Chemical compound ClC(=O)C1CCCCC1 RVOJTCZRIKWHDX-UHFFFAOYSA-N 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 2
239000003208 petroleum Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
241000219198 Brassica Species 0.000 description 1
235000003351 Brassica cretica Nutrition 0.000 description 1
235000003343 Brassica rupestris Nutrition 0.000 description 1
VUGQIIQFXCXZJU-UHFFFAOYSA-N CC(c(cc1OC)cc(OC)c1OC)=O Chemical compound CC(c(cc1OC)cc(OC)c1OC)=O VUGQIIQFXCXZJU-UHFFFAOYSA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
108010003541 Platelet Activating Factor Proteins 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000007059 acute toxicity Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
238000013019 agitation Methods 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000002253 anti-ischaemic effect Effects 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
230000001746 atrial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
239000002775 capsule Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
230000008859 change Effects 0.000 description 1
125000000068 chlorophenyl group Chemical group 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
238000001914 filtration Methods 0.000 description 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
239000010410 layer Substances 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
235000010460 mustard Nutrition 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 1
REEZZSHJLXOIHL-UHFFFAOYSA-N octanoyl chloride Chemical compound CCCCCCCC(Cl)=O REEZZSHJLXOIHL-UHFFFAOYSA-N 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
ISYGJWPNTJUYRF-UHFFFAOYSA-N piperazin-2-ylmethyl cyclohexanecarboxylate Chemical compound C1CCCCC1C(=O)OCC1CNCCN1 ISYGJWPNTJUYRF-UHFFFAOYSA-N 0.000 description 1
238000010992 reflux Methods 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
125000001680 trimethoxyphenyl group Chemical group 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

LU87605A 1988-10-11 1989-10-10 Nouveaux derives de la methoxycarbonyl-2 n-n'-di-(trimethoxy-benzoyle)piperazine,un procede pour leur preparation et compositions therapeutiques en contenant LU87605A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8823776		1988-10-11
GB888823776A GB8823776D0 (en)	1988-10-11	1988-10-11	New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines

Publications (1)

Publication Number	Publication Date
LU87605A1 true LU87605A1 (fr)	1990-02-07

Family

ID=10644989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU87605A LU87605A1 (fr)	1988-10-11	1989-10-10	Nouveaux derives de la methoxycarbonyl-2 n-n'-di-(trimethoxy-benzoyle)piperazine,un procede pour leur preparation et compositions therapeutiques en contenant

Country Status (33)

Country	Link
US (1)	US4927825A (de)
JP (1)	JPH0635451B2 (de)
KR (1)	KR970004913B1 (de)
AR (1)	AR245111A1 (de)
AT (1)	AT395422B (de)
AU (1)	AU619146B2 (de)
BE (1)	BE1003518A3 (de)
CA (1)	CA1319692C (de)
CH (1)	CH679858A5 (de)
DE (1)	DE3933882C2 (de)
DK (1)	DK500489A (de)
DZ (1)	DZ1366A1 (de)
ES (1)	ES2018404A6 (de)
FI (1)	FI96855C (de)
FR (2)	FR2637592B1 (de)
GB (2)	GB8823776D0 (de)
GR (1)	GR1000359B (de)
HK (1)	HK47492A (de)
IE (1)	IE61621B1 (de)
IN (1)	IN173326B (de)
IT (1)	IT1237087B (de)
LU (1)	LU87605A1 (de)
MA (1)	MA21651A1 (de)
MY (1)	MY105852A (de)
NL (1)	NL8902519A (de)
NO (1)	NO176179C (de)
NZ (1)	NZ230928A (de)
OA (1)	OA09429A (de)
PT (1)	PT91940B (de)
SE (1)	SE505222C2 (de)
SG (1)	SG40592G (de)
TN (1)	TNSN89109A1 (de)
ZA (1)	ZA897553B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8823775D0 (en) *	1988-10-11	1988-11-16	Scras	New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8908587D0 (en) *	1989-04-15	1989-06-01	Scras Societe De Conseils De R	New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
FR2780649B1 (fr) *	1998-07-06	2001-03-09	Univ Paris Vii Denis Diderot	Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3318876A (en) *	1962-12-11	1967-05-09	Lepetit Spa	Substituted piperazines and process for preparing same
GB1243991A (en) *	1968-06-10	1971-08-25	Ici Ltd	Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) *	1972-12-07	1974-07-05	Degussa	N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IT1194819B (it) *	1980-11-20	1988-09-28	Selvi & C Spa	Derivati della piperazina,procedimento per la loro preparazione e relative composizioni farmaceutiche
GB8427735D0 (en) *	1984-11-02	1984-12-12	Fujisawa Pharmaceutical Co	Piperazine compound
FR2581993B1 (fr) *	1985-05-14	1988-03-18	Synthelabo	Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
US4824996A (en) *	1986-08-12	1989-04-25	American Home Products Corporation	Phospholipase A2 inhibitors
IL85700A0 (en) *	1987-03-24	1988-08-31	Takeda Chemical Industries Ltd	1,4-disubstituted piperazine compounds,their production and use
GB8823775D0 (en) *	1988-10-11	1988-11-16	Scras	New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines

1988
- 1988-10-11 GB GB888823776A patent/GB8823776D0/en active Pending
1989
- 1989-09-29 CA CA000615180A patent/CA1319692C/en not_active Expired - Fee Related
- 1989-10-03 IN IN876DE1989 patent/IN173326B/en unknown
- 1989-10-04 ZA ZA897553A patent/ZA897553B/xx unknown
- 1989-10-06 NZ NZ230928A patent/NZ230928A/xx unknown
- 1989-10-06 US US07/418,113 patent/US4927825A/en not_active Expired - Lifetime
- 1989-10-06 CH CH3657/89A patent/CH679858A5/fr not_active IP Right Cessation
- 1989-10-09 DZ DZ890158A patent/DZ1366A1/fr active
- 1989-10-09 GR GR890100646A patent/GR1000359B/el not_active IP Right Cessation
- 1989-10-09 SE SE8903313A patent/SE505222C2/sv not_active IP Right Cessation
- 1989-10-10 PT PT91940A patent/PT91940B/pt not_active IP Right Cessation
- 1989-10-10 KR KR1019890014507A patent/KR970004913B1/ko not_active Expired - Fee Related
- 1989-10-10 BE BE8901088A patent/BE1003518A3/fr not_active IP Right Cessation
- 1989-10-10 DK DK500489A patent/DK500489A/da not_active Application Discontinuation
- 1989-10-10 NO NO894037A patent/NO176179C/no not_active IP Right Cessation
- 1989-10-10 ES ES8903411A patent/ES2018404A6/es not_active Expired - Lifetime
- 1989-10-10 AR AR89315125A patent/AR245111A1/es active
- 1989-10-10 IE IE325789A patent/IE61621B1/en not_active IP Right Cessation
- 1989-10-10 TN TNTNSN89109A patent/TNSN89109A1/fr unknown
- 1989-10-10 MA MA21903A patent/MA21651A1/fr unknown
- 1989-10-10 LU LU87605A patent/LU87605A1/fr unknown
- 1989-10-10 MY MYPI89001393A patent/MY105852A/en unknown
- 1989-10-10 AU AU42687/89A patent/AU619146B2/en not_active Ceased
- 1989-10-11 GB GB8922854A patent/GB2224027B/en not_active Expired - Lifetime
- 1989-10-11 FR FR8913259A patent/FR2637592B1/fr not_active Expired - Lifetime
- 1989-10-11 NL NL8902519A patent/NL8902519A/nl not_active Application Discontinuation
- 1989-10-11 IT IT02199089A patent/IT1237087B/it active IP Right Grant
- 1989-10-11 DE DE3933882A patent/DE3933882C2/de not_active Expired - Fee Related
- 1989-10-11 FR FR898913258A patent/FR2637499B1/fr not_active Expired - Lifetime
- 1989-10-11 FI FI894813A patent/FI96855C/fi not_active IP Right Cessation
- 1989-10-11 JP JP1263141A patent/JPH0635451B2/ja not_active Expired - Lifetime
- 1989-10-11 AT AT0234589A patent/AT395422B/de not_active IP Right Cessation
- 1989-10-11 OA OA59662A patent/OA09429A/xx unknown
1992
- 1992-04-14 SG SG405/92A patent/SG40592G/en unknown
- 1992-07-02 HK HK474/92A patent/HK47492A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IE61621B1 (en)	1994-11-16
NL8902519A (nl)	1990-05-01
ATA234589A (de)	1992-05-15
OA09429A (fr)	1992-10-15
FR2637499A1 (fr)	1990-04-13
GB8823776D0 (en)	1988-11-16
AR245111A1 (es)	1993-12-30
IT8921990A0 (it)	1989-10-11
HK47492A (en)	1992-07-10
FI96855B (fi)	1996-05-31
FR2637592A1 (fr)	1990-04-13
AU619146B2 (en)	1992-01-16
GR890100646A (en)	1990-11-29
IT1237087B (it)	1993-05-18
MA21651A1 (fr)	1990-07-01
NO176179C (no)	1995-02-15
FI96855C (fi)	1996-09-10
JPH02196775A (ja)	1990-08-03
SG40592G (en)	1992-06-12
FR2637499B1 (fr)	1992-06-05
NO894037D0 (no)	1989-10-10
ES2018404A6 (es)	1991-04-01
AU4268789A (en)	1990-04-26
GB2224027B (en)	1992-01-15
US4927825A (en)	1990-05-22
GB2224027A (en)	1990-04-25
KR900006310A (ko)	1990-05-07
DK500489A (da)	1990-04-12
DE3933882C2 (de)	1993-10-07
DE3933882A1 (de)	1990-04-19
JPH0635451B2 (ja)	1994-05-11
FR2637592B1 (fr)	1992-10-23
IE893257L (en)	1990-04-11
FI894813A0 (fi)	1989-10-11
DZ1366A1 (fr)	2004-09-13
MY105852A (en)	1995-01-30
SE8903313D0 (sv)	1989-10-09
CH679858A5 (de)	1992-04-30
ZA897553B (en)	1990-10-31
BE1003518A3 (fr)	1992-04-14
CA1319692C (en)	1993-06-29
PT91940A (pt)	1990-04-30
SE8903313L (sv)	1990-04-12
DK500489D0 (da)	1989-10-10
GB8922854D0 (en)	1989-11-29
IN173326B (de)	1994-04-02
NZ230928A (en)	1990-08-28
NO894037L (no)	1990-04-17
NO176179B (no)	1994-11-07
FI894813L (fi)	1990-04-12
IT8921990A1 (it)	1991-04-11
PT91940B (pt)	1995-05-31
TNSN89109A1 (fr)	1991-02-04
AT395422B (de)	1992-12-28
GR1000359B (el)	1992-06-30
KR970004913B1 (ko)	1997-04-08
SE505222C2 (sv)	1997-07-21

Publication	Publication Date	Title
FR2936798A1 (fr)	2010-04-09	Nouveaux composes heterocycliques azotes, leur praparation et leur utilisation comme medicaments antibacteriens.
EP0231139B1 (de)	1991-12-04	Dihydrobenzofuran- und Chromancarboxamid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Neuroleptica
FR2476088A2 (fr)	1981-08-21	Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
CA2184754A1 (fr)	1995-10-05	Derives de 5h-indeno[1,2-b]pyrazine-2,3-dione, leur preparation et les medicaments les contenant
WO1995002601A1 (fr)	1995-01-26	DERIVES D'IMIDAZO[1,2-a]PYRAZIN-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
WO2000032574A1 (fr)	2000-06-08	Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
EP0789699B1 (de)	1999-03-17	SPIRO[HETEROZYCLISCHE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN]-4'-ONE, IHRE HERSTELLUNG UND DIESE ENTHALTENDE ARZNEIMITTEL
WO1997025329A1 (fr)	1997-07-17	DERIVES DE 5H,10H-IMIDAZO[1,2-a]INDOLO[3,2-e]PYRAZINE-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
BE1007245A3 (fr)	1995-05-02	Derives di-substitues des n, n'-ditrimethoxybenzoyle piperazine, un procede pour leur preparation et compositions therapeutiques en contenant.
BE1003519A3 (fr)	1992-04-14	Nouveaux derives de la carbonyl-2 n,n'-di-(trimethoxybenzoyle) piperazine, un procede pour leur preparation et compositions therapeutiques en contenant.
BE1003518A3 (fr)	1992-04-14	Nouveaux derives de la methoxycarbonyl-2-n,n'-di-(trimethoxybenzoyle) piperazine, un procede pour leur preparation et compositions therapeutiques en contenant.
EP1001944B1 (de)	2003-10-01	Pyrazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0256936A1 (de)	1988-02-24	4-Benzylpiperazinderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
FR2611139A1 (fr)	1988-08-26	Medicaments a base de nouveaux derives oxy-5 du tetrahydrofurane
FR2615735A1 (fr)	1988-12-02	Compositions therapeutiques a base de nouveaux (o-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes
EP0153890A2 (de)	1985-09-04	Derivate von 3-Phenyl-2-propenamin, ihre Herstellung und diese enthaltende Arzneimittel
FR2615736A1 (fr)	1988-12-02	Compositions therapeutiques a base de nouveaux methoxy-5 alcoyl ammonium tetrahydrofuranes et tetrahydrothiophenes
BE806848A (fr)	1974-04-30	Medicament a base d'un derive de la quinoleine
FR2516510A1 (fr)	1983-05-20	Derives de la (trimethoxy-3,4,5-cinnamoyl)-1-aminocarbonylethyl-4-piperazine substituee utilisables en pharmacie et procede pour leur preparation
EP0100257B1 (de)	1988-02-24	Aminoalkylnaphthalen-Derivate, ihre Salze und Verfahren zu ihrer Herstellung und die Verwendung dieser Derivate und Salze in der Therapeutik
EP0347305B1 (de)	1993-05-12	[(Aryl-4-piperazinyl-1)-2-ethoxy]-3p-cymole, die ortho-, meta-, para-monosubstituierten oder disubstituierten Derivate, das Verfahren zu deren Herstellung und die als aktives Prinzip diese Verbindungen enthaltenden Arzneimittel
EP0119896A1 (de)	1984-09-26	5-Amino-1,2-dithiol-3-on-Derivate, ihre Herstellung und diese enthaltende medizinische Zusammenstellungen
EP0203902A2 (de)	1986-12-03	1,2,3,4,5,6-Hexahydroazepino[4,5-b]-indolderivate, ihre Herstellung, Zwischenverbindungen und ihre therapeutische Anwendung
LU81146A1 (fr)	1980-12-16	Esters benzylideniques et leur application en therapeutique
FR2706463A1 (fr)	1994-12-23	Nouveaux dérivés d'aziridino spirodiazaalkylcyclotriphosphazènes substitués leur procédé de préparation et leur utilisation en tant que médicament.